Development of a quantitative method for evaluating small intestinal motility using ultrasonography in mice

Area of Science:

• Gastroenterology
• Medical Imaging
• Pharmacology

Background:

• Upper gastrointestinal (GI) motility is crucial for digestive health but is poorly understood in disease states.
• Limited in vivo quantitative methods exist for assessing small intestinal motility in mice.
• Ultrasonography is a noninvasive imaging technique applicable to abdominal organ evaluation.

Purpose of the Study:

• To establish a novel ultrasonography-based method for quantifying in vivo small intestinal motility in mice.
• To validate this method by assessing the effects of loperamide on GI motility.

Main Methods:

• Mice were treated with and without loperamide, an antidiarrheal medication.
• GI motility was assessed using dye transit, a 13C-octanoic acid breath test, and ultrasonography.
• Duodenal wall locomotion activity was quantified via ultrasonography to measure GI motility.

Main Results:

• Loperamide significantly delayed upper GI transit and decreased gastric emptying.
• Ultrasonography revealed suppressed duodenal peristalsis and enlarged duodenal lumen in loperamide-treated mice, indicating reduced motility.
• Quantifiable duodenal locomotion activity was significantly decreased following loperamide administration.

Conclusions:

• Ultrasonography provides an effective in vivo method for quantifying small intestinal motility in mice.
• This technique can assess drug-induced changes in GI motility.
• The findings support ultrasonography as a valuable tool for studying GI motility in preclinical research.